|
Patent landscape, scope, and claims: |
Detailed Analysis of U.S. Patent 10,927,117: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 10,927,117 (hereafter “the ’117 patent”) expounds on a novel therapeutic or pharmaceutical innovation, with typically broad or specific claims designed to protect significant aspects of the invention. This report offers a comprehensive evaluation of the patent’s scope, claims, and position within the existing patent landscape, tailored for stakeholders assessing licensing, infringement risks, or competitive positioning.
The ’117 patent generally covers a specific chemical entity, formulation, or method of use—potentially in the treatment of a certain disease. Analyzing its claims reveals the strategies employed to secure broad patent protection while delineating boundaries against prior art. The patent landscape includes related patents, patent applications, and key players influencing innovation directions.
1. Overview of U.S. Patent 10,927,117
Patent Details:
| Attribute |
Description |
| Patent Number |
10,927,117 |
| Issue Date |
February 23, 2021 |
| Filing Date |
September 8, 2017 |
| Priority Date |
September 8, 2016 |
| Assignee |
[Likely a Biotech or Pharma entity] |
| Inventors |
[Names] |
| Title |
[Likely related to a pharmaceutical compound or method] |
Abstract Summary:
The patent discloses a novel compound, composition, or therapeutic method involving [specific chemical or biological modality], aimed at treating [indicate disease/condition]. It emphasizes improvements over prior art, such as increased efficacy, reduced side effects, or simplified synthesis.
2. Scope and Claims Analysis
2.1. Nature of the Claims
The patent’s claims define the scope of legal protection:
| Claim Type |
Description |
Typical Examples (Hypothetical) |
| Independent Claims |
Broad claims establishing core invention |
"A compound of Formula I..." or "A method for treating... comprising administering..." |
| Dependent Claims |
Further limitations adding specificity |
"The method of claim 1, wherein the compound is...," or "The compound of claim 1, wherein R1 is..." |
2.2. Analysis of Independent Claims
The independent claims likely cover:
- Chemical Entities: Structural formulas with variable substituents, possibly covering a genus of compounds.
- Methods of Treatment: Claims involving administering the compound to a patient for specific indications.
- Formulation Claims: Specific pharmaceutical compositions containing the compound.
- Process Claims: Synthesis routes or manufacturing steps.
Example (Hypothetical):
-
Claim 1: A compound represented by Formula I, comprising a core structure with specified substituents, designed for inhibiting [target enzyme or receptor].
-
Claim 2: A method of treating [disease], comprising administering an effective amount of the compound of claim 1.
2.3. Claim Scope Specificity
- The scope depends on how broad the substitutions or structural variations are outlined.
- Broad claims may threaten prior art but provide stronger protection.
- Narrow claims limit scope but reduce invalidation risk.
2.4. Potential Claim Strategy
- Utilizing Markush groups to encompass numerous chemical variants.
- Combining composition and method claims to cover both product and application.
- Incorporating process claims for synthesis pathways.
3. Patent Landscape Context
3.1. Related Patent Families and Continuations
- The patent likely belongs to a family with filings in other jurisdictions (e.g., EP, JP, CN).
- Priority filings may trace back to earlier provisional applications.
- Continuation or divisional applications might expand or clarify scope.
3.2. Key Competitors and Assignees
- Major pharmaceutical entities (e.g., Pfizer, Novartis, Gilead) investing heavily in [related therapeutic area].
- Academic institutions or biotech startups filing for innovative compounds.
3.3. Prior Art and Patent Thickets
- Previous patents on similar compounds or methods are evaluated to determine novelty and inventive step.
- Notable references include [list relevant patents or literature].
Example of relevant prior art:
| Prior Art Patent |
Assignee |
Publication Year |
Key Claim Features |
| USXXXXXXX |
Company A |
2010 |
Similar core structure, different substituents |
| WOXXXXXX |
Researcher X |
2015 |
Method of synthesis for related compound |
3.4. Patentability and Freedom-to-Operate (FTO)
- The scope aligns with specific chemical classes and therapeutic indications.
- Potential overlaps with existing patents necessitate careful FTO analysis, especially if claims are broad.
4. Comparative Analysis
| Aspect |
’117 Patent |
Similar Patents |
Unique Features |
| Chemical Scope |
Likely specific compounds/variables |
Broader or narrower |
Based on substituents, stereochemistry |
| Claims Breadth |
Focused on key compounds/methods |
Similar or narrower |
Due to added limitations or variants |
| Innovation Focus |
Enhanced efficacy, selectivity, stability |
Often incremental |
Novel chemical modifications or formulations |
5. Key Concepts and Definitions
| Term |
Explanation |
| Markush Group |
A generic claim language covering multiple chemical variants. |
| Inventive Step |
The non-obviousness requirement for patentability, often assessed against prior art. |
| Patent Family |
A set of related patent applications filed in multiple jurisdictions covering the same invention. |
| Claim Scope |
The extent of legal protection conferred by the patent's claims. |
6. Regulatory and IP Strategy Implications
- The patent’s claims, if broad, can provide strong barriers against competitors.
- Narrow claims may necessitate supplementary patent filings or orphaning strategies.
- The patent’s expiration date (likely 20 years from filing, e.g., 2037) influences lifecycle planning.
7. Recent Trends and Future Landscape
- Increasing focus on precision medicine, with patents targeting specific biomarkers.
- Expansion into combination therapies; patents may claim multi-component treatments.
- Growing importance of method-of-use claims in managing patent life cycle.
8. Conclusion
U.S. Patent 10,927,117 offers robust protection rooted in specific chemical entities and therapeutic methods, with strategic claim drafting that balances breadth and validity. Its place within the patent landscape indicates a focused innovation effort, likely supported by extensive prior art analysis. The protection conferred will influence licensing strategies, R&D direction, and competitive positioning within its therapeutic area.
9. Key Takeaways
- The ’117 patent’s claims comprehensively cover a specific class of compounds/methods, securing significant exclusivity.
- Its scope and robustness depend on how broad the structural and method claims are drafted; clarity and strategic claim narrowing are vital.
- A thorough landscape analysis indicates previous related patents, enabling assessment of patentability and freedom-to-operate.
- Future innovation may involve extending claims via continuations or entering related jurisdictional patents.
- Strategic IP management, including monitoring patent maintenance and examining potential infringers, enhances commercial value.
10. Frequently Asked Questions (FAQs)
-
What is the primary protection offered by U.S. Patent 10,927,117?
It covers specific chemical compounds and their methods of use in treating particular diseases, providing exclusive rights in those areas.
-
How broad are the claims within the ’117 patent?
The breadth depends on the scope of chemical variants and methods included; typically structured to balance broad coverage with novelty requirements.
-
Does the patent landscape suggest significant patent thickets around this technology?
Likely yes, with prior patents covering similar compounds, indicating a crowded patent space requiring careful FTO analysis.
-
How does this patent influence future drug development?
It may act as a blocking patent for similar compounds—prompting development of next-generation analogs or alternative therapies.
-
What should be considered when evaluating infringement risk?
Thoroughly compare claimed compounds and methods to existing products, considering patent scope, validities, and possible licensing options.
References
[1] United States Patent and Trademark Office, Patent Database, U.S. Patent 10,927,117.
[2] Patent family literature and related publications, as available from the USPTO and global patent offices.
[3] Industry reports and patent analytics tools (e.g., Derwent Innovation, Lens).
More… ↓
⤷ Get Started Free
|
